Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes

Am J Physiol. 1997 Jan;272(1 Pt 2):H35-47. doi: 10.1152/ajpheart.1997.272.1.H35.

Abstract

Recent work has demonstrated that endotoxin or cytokines induce nitric oxide synthase in heart or cardiac myocytes. We investigated the functional significance of inducible nitric oxide synthase (iNOS) in indo 1-loaded beating myocytes with regard to intracellular Ca2+ concentration ([Ca2+]i) and cell contraction. Lipopolysaccharide (LPS; 10 micrograms/ml) time dependently induced iNOS mRNA and protein in cultured neonatal rat cardiac myocytes. Nitrite concentration in the medium and intracellular guanosine 3',5'-cyclic monophosphate (cGMP) contents after 24-h exposure to LPS increased in proportion to the levels of iNOS induction in these cells. Myocytes treated with both NG-monomethyl-L-arginine and LPS for 24 h expressed iNOS protein, but nitrite production was significantly inhibited. Subsequent perfusion with 100-fold molar excess L-arginine of these myocytes elicited decreases in peak systolic [Ca2+]i (790 +/- 42 to 551 +/- 27 nM, P < 0.05), relative amplitude of cell contraction (100 to 72.4 +/- 5.5%, P < 0.05), and spontaneous beating rate (146 +/- 13 to 85 +/- 22 beats/min, P < 0.05). Pretreatment with methylene blue or KT-5823 inhibited these negative myocardial effects. These results suggest that LPS induces iNOS in cardiac myocytes and that the increased nitric oxide produced by iNOS has cardiac depressant effects through the activation of cGMP-dependent protein kinase.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Cells, Cultured
  • Cyclic GMP / physiology
  • Enzyme Induction
  • Enzyme Inhibitors / pharmacology
  • Heart / drug effects
  • Heart / physiology*
  • Intracellular Membranes / metabolism
  • Lipopolysaccharides / pharmacology
  • Myocardial Contraction
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Nitric Oxide / physiology
  • Nitric Oxide Synthase / physiology*
  • Rats
  • Rats, Wistar
  • omega-N-Methylarginine / pharmacology

Substances

  • Enzyme Inhibitors
  • Lipopolysaccharides
  • omega-N-Methylarginine
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Cyclic GMP
  • Calcium